Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial.

Sensitivity 91.37%, specificity 95.09%.

Mol Cancer 2024;23(1):57. UI-Seek.PubMed 38504268